Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Mai 2018 07:30 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Presents Poster on Preclinical Data from ATYR1923 Program at American Thoracic Society 2018 International Conference

SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
14. Mai 2018 06:45 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces First Quarter 2018 Operating Results, Program Prioritization and Corporate Restructuring

SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
08. Mai 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
02. Mai 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting

SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
19. März 2018 16:05 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate Update

SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
07. März 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Host Conference Call and Webcast of Full Year 2017 Financial Results on March 19, 2018

SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
01. März 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Present at Two Upcoming Investor Conferences in March

SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
04. Januar 2018 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
21. Dezember 2017 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium

SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat...
07. Dezember 2017 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma to Participate at the BMO Prescriptions for Success Healthcare Conference

SAN DIEGO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of immuno-modulatory protein therapeutics to treat...

Vorherige Seite

Nächste Seite